Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

Call for Abstracts - SNO 22nd Annual Scientific Meeting

Submission Deadline June 12, 2017

Read Full Story

REGISTER NOW - SNO Pediatric Research Conference

Join us in the Big Apple, New York City! Read for registration, exhibit/support opportunities, program ...

Read Full Story

Call for Proposals - Neuro-Oncology Courses

Deadline April 30 for courses to be held in developing countries

Read Full Story
View All News


5th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies (WFNOS)

Read Full Story


Brain Tumor Berlin 2017

Read Full Story


5th International CNS Germ Cell Tumor Symposium

Read Full Story

2016 Independent Supported Symposia


At the 21st Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO), there will be multiple Independent Supported Symposia (ISS) Sessions.  Lunch-time ISS sessions will be held on Friday and Saturday and evening ISS sessions will be held on Thursday and Friday evenings. 


Thursday, November 17, 2016

Evening ISS session:  5:30pm – 7:30pm

Title: New Considerations for the Treatment of Glioblastoma Multiforme (GBM): Evaluating the Potential for Immune Checkpoint Inhibitors
Supported by a grant by Bristol Myers-Squibb.

Location: Palomino 1 - 5 

Michael Lim, MD - Johns Hopkins University
John H. Sampson, MD, PhD, MBA - Duke University
David Reardon, MD - Dana Farber Cancer Institute

Overview and Activity Goals
Michael Lim

Reassessing the Notion that GBM Is Immune Privileged
John H. Sampson

Current Standard of Care and Clinical Challenges with GBM in the Setting of Immunotherapy
David A. Reardon

Future Directions for Immunotherapy
Michael Lim

Conclusions and Postassessment
Michael Lim

Registration: To register, visit

Friday, November 18, 2016

Lunch-time ISS sessions:  12:15pm – 1:15pm

Title: The changing landscape of Management of Brain Metastases
Supported by American Brain Tumor Association.

Location: Moor 3

Chair:  Manmeet Ahluwalia - Cleveland Clinic

Paul Brown - Mayo Clinic
Manmeet Ahluwalia - Cleveland Clinic
Priscilla Brastianos - Massachusetts General Hospital

The evolving role of Radiation Therapy in Brain Metastases
Paul Brown

Targeted and Immunotherapy Therapy in Brain Metastases: Ready for Primetime?
Manmeet Ahluwalia

Genomic profiling of brain metastases and Emerging Therapies for Brain Metastases
Priscilla Brastianos

Title: Clinical Perspectives on Optune: A Caseā€Based Approach
Supported by Novocure. 

Location:  Palomino 1-5

Daniela Bota - University of California, Irvine
Maciej M. Mrugala - University of Washington, Seattle

Registration: To RSVP, please send RSVP to  

Title: Impact of Pre-Surgical Transcranial Magnetic Stimulation on Glioma Management

Supported by Nexstim.

Location: Palomino 6-10

Phiroz Tarapore - UCSF
Sebastian Ille - Technische Universitaet Munich

Evening ISS sessions:  5:30pm – 7:30pm

Title: Novalis Circle Symposium:  Neurosurgery Developments in the Treatment of High Grade Gliomas
Supported by Brainlab.  

Location: Golden and Dorado

Orin Bloch, MD - Northwestern Memorial Hospital, United States
Andrew Brenner, MD - University of Texas San Antonio, United States
Yael Mardor, MD - Sheba Medical Center, Israel

Surgically-Based Clinical Trials for GBM: Heat Shock Protein Vaccination
Orin Bloch

Clinical Experience with Rhenium Nanoliposomes
Andrew Brenner

Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues in Gliomas
Yael Mardor

Registration:  For more information and to register, please visit


Title: Personalized Medicine for GBM: What Does the Future Hold?                      
Supported by AbbVie. 

Location: Palomino 1-5

Chair:  Martin van den Bent - Erasmus MC Cancer Center

Martin van Bent - Erasmus MC Cancer Center
Albert Lai - David Geffen School of Medicine, UCLA
Hui Gan - Olivia Newton-John Cancer Research Institute and Austin Hospital
Patrick Y. Wen - Harvard Medical School and Dana-Farber Brigham and Women’s Cancer Center

Biomarkers and WHO Classification in 2016: The Clinician’s Perspective
Martin van den Bent

The Role of MGMT Methylation Status in the Evolving Targeted GBM Treatment Landscape
Albert Lai            

Targeting EGFR: Where Do We Stand Today?
Hui Gan

Personalized Medicine Initiatives in Clinical Trials
Patrick Y. Wen 

Registration:  For more information and to register, click here.  

Saturday, November 19, 2016: 

Lunch-time ISS sessions:  12:15pm – 1:15pm

Title: Anticipating the Promise of Immunotherapy in GBM
Supported by a grant by AbbVie.

Location:  Palomino 1-5

Chair: David Reardon - Dana-Farber Cancer Institute

David Reardon, MD - Dana-Farber Cancer Institute
Amy B. Heimberger, MD - The University of Texas MD Anderson Cancer Center
John Sampson, MD, PhD - Duke University

Elucidating the rationale for immunotherapy
Amy Heimberger

Defining and exploiting specific targets in glioblastoma: Passive immunotherapy
John Sampson

prIME Points
David Reardon

Registration: To register please visit: 


Title: Live from Scottsdale- FAQs and Best Practices in the Management of Glioblastoma
Supported by a grant by Novocure.

Location:  Palomino 6-10

Chair: Herbert B. Newton, MD, FAAN - Florida Hospital Cancer Institute, Ohio State University Medical Center, and James Cancer Hospital

Steven A. Toms, MD - Warren Albert Medical School, Brown University
Roger Stupp, MD - University of Zurich, University of Zurich Hospital

Patient Case 1:  Clinical Decision Making in the Newly Diagnosed Patient
Patient Case 2:  Clinical Decision Making in the Patient with Reoccuring Disease
Panel Discussion: Multidisciplinary Management and Coordination Throughout the Patient's Continuum of Care

Registration:  To register, please visit: